Mateusz Kaczmarek, Author at TechStock²

AI Buzz Lifts Pegasystems Stock – Pega Shares Soar on Strong Q3 Results and New Platform Launch

Earnings Beat Propels Stock: On October 21, Pega reported Q3 FY2025 results that handily beat forecasts. Quarterly revenue hit $381.4 million, up 17% from a year ago and above the $351M consensus, and adjusted EPS jumped to $0.30 (versus ~

22 October 2025

Avadel Stock Rockets on $2.1B Alkermes Buyout Offer – Key Developments & Analyst Takeaways

Alkermes Buyout Sparks Rally in AVDL Stock On Oct. 22, 2025, Alkermes announced it would acquire Avadel for $18.50 cash per share plus a $1.50 contingent value right (CVR) tied to an FDA approval for idiopathic hypersomnia, valuing the deal

22 October 2025

Financial News · Investment Analysis · Mergers & Acquisitions · NASDAQ:ALKS · NASDAQ:AVDL · NASDAQ:JAZZ · Pharmaceuticals · Stock Market

Amphenol (APH) Stock Soars on Record Q3 and AI Boom – Analysts Target $150

Amphenol’s stock (NYSE: APH) has erupted this October amid record results and AI-driven demand. The connectors-and-sensors maker is capitalizing on the tech boom. Record-Breaking Q3 Results and Guidance Amphenol’s Q3 2025 results (announced Oct 22) were truly outstanding. Sales hit

22 October 2025

AI Trends · Earnings Reports · Investment Analysis · NYSE:APH · Stock Market · Technology

Applied DNA (BNBX) Stock Surges on $58M Binance BNB Crypto Bet; New Ticker Takes Effect

Recent Market Performance Applied DNA’s share price has been extremely volatile amid its strategic shifts. According to market data, BNBX closed at $3.42 on Oct. 21 (down 2.0% that day) marketscreener.com. It then jumped after hours on Oct. 22 with news of

22 October 2025

Applied DNA · Cryptocurrency · Financial News · Investments · NASDAQ:BNBX · Stock Market

Arcturus Therapeutics Stock Soars to New High Then Crashes on Trial Data – What Investors Need to Know

Stock Performance & Analyst Sentiment Arcturus stock had been riding a wave of positive sentiment through October 2025. On Oct 21 it closed at $23.16 – its highest level in a year marketbeat.com – following stronger-than-expected Q2 results (earnings beat

22 October 2025

Biotech News · Financial Analysis · Investment Tips · NASDAQ:ARCT · Pharma Industry · Stock Market

Beneficient (BENF) Stock Skyrockets 64% After CEO Converts $52M Preferred into Common

Benficient stock (NASDAQ: BENF) closed Oct 21 at ~$0.49 and jumped ~64% to ~$0.80 after hours when Chairman Thomas O. Hicks and Interim CEO James Silk converted $52.6 M of preferred units into Class A shares investing.com benzinga.com. The company is

22 October 2025

CEO Actions · Company Updates · Financial Analysis · Investing News · NASDAQ:BENF · Stock Market

Vicor Stock Skyrockets to 52-Week High After Blockbuster Q3 and AI Licensing Boom

Vicor Corporation (NASDAQ: VICR) shares surged after its Oct. 21 Q3 report, reaching ~$67.82 intraday on Oct. 21 (vs ~$58 the prior close) marketbeat.com. The stock is up roughly 30–35% year-to-date (fell to ~$38 low in 2024) and opened Oct 22 near $65–66.

22 October 2025

AI Technology · Earnings Reports · Financial News · Investing · NASDAQ:VICR · Stock Market

AST SpaceMobile Stock Shoots for the Stars – Verizon Deal and Satellite Breakthroughs Ignite 300% Rally

Stock Price and Recent Performance AST SpaceMobile’s stock has been one of 2025’s hottest stories. After trading around $30 in late 2024, ASTS rallied over 300% this year on a wave of positive news ts2.tech ts2.tech. In early October the

22 October 2025

Business News · Investing · NASDAQ:ASTS · Satellite Communication · Space Technology · Stock Market

Will SBEV Pop or Flop? Splash Beverage Group Stock Surges on Big Deals – Analysts Weigh In

Stock Price and Performance Splash Beverage Group (NASDAQ: SBEV) stock has seen dramatic swings in 2025. After trading under $1 for much of early 2025, the shares climbed steeply in the spring, peaking above $13.50. By late October however, SBEV

22 October 2025

Analyst Opinions · Beverage Industry · Financial News · Investments · NYSE:SBEV · Stock Market

VSee Health (VSEE) Stock Skyrockets 75% on $10M Hospital Teleradiology Contract

Teleradiology Contract Ignites Stock Rally On Oct. 21 VSee Health (NASDAQ: VSEE) stunned the market by announcing a landmark teleradiology services agreement with a major Level-1 trauma hospital system. The multi-year deal – which began service in June – is

22 October 2025

Business News · Healthcare Technology · Investments · Stock Market · Teleradiology

Boston Scientific Stock Rockets on Blowout Q3 Results and Major Medical Wins

Boston Scientific’s Q3 report blew past expectations. Marlborough, MA-based Boston Scientific (NYSE:BSX) posted reported net income of $755 M ($0.51/share GAAP) and adjusted EPS of $0.75 timesunion.com chartmill.com, topping the $0.71–$0.72 analysts’ forecast. CEO Mike Mahoney called it “another exceptional quarter

22 October 2025

Earnings Reports · Investing · Market News · Medical Technology · Stocks

Novo Nordisk (NVO) Stock Tanks as Weight-Loss Empire Faces Boardroom Coup and Fierce Rivalry

Boardroom Shake-Up Spurs Investor Nerves Novo’s stock slide accelerated this week amid a dramatic boardroom conflict. On Oct. 21, the Novo Nordisk Foundation (the company’s controlling shareholder) announced it would remove chair Helge Lund and six other independent directors. A

22 October 2025

Business Rivalry · Corporate News · NYSE:NVO · Pharmaceuticals · Stock Market · Weight Loss